{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:40:10Z","timestamp":1759120810049,"version":"3.44.0"},"reference-count":102,"publisher":"Bentham Science Publishers Ltd.","issue":"32","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>This study discusses the chemical perspectives of the [&lt;sup&gt;18&lt;\/sup&gt;F]F-PSMA probe, a\npivotal tool in prostate cancer imaging. [&lt;sup&gt;18&lt;\/sup&gt;F]Fluorine, a positron emitter with a half-life\nof 109.8 minutes, is produced in a cyclotron by bombarding [18O]-enriched targets with\nprotons. The chemistry of this isotope parallels that of stable fluorine, facilitating its use\nin positron emission tomography (PET). The synthesis of [&lt;sup&gt;18&lt;\/sup&gt;F]F-PSMA involves a nucleophilic\nsubstitution (SN1) reaction, where [&lt;sup&gt;18&lt;\/sup&gt;F]fluoride ion replaces a leaving group\nin the precursor molecule. Prostate-specific membrane antigen (PSMA) is highly expressed\nin prostate cancer cells, making it a crucial target for imaging. PSMA-targeted\nradioligands, such as [&lt;sup&gt;68&lt;\/sup&gt;Ga]Ga-PSMA-11, [&lt;sup&gt;18&lt;\/sup&gt;F]F-DCFPyL, and [&lt;sup&gt;99&lt;\/sup&gt;mTc]Tc-PSMA-I&amp;S,\nbind to the extracellular domain of PSMA, enabling precise imaging. The design of PSMA\nradiotracers incorporates specific targeting moieties, functional groups for radiolabeling,\nand linkers to maintain binding affinity and pharmacokinetics. Common linkers\ninclude aliphatic, aromatic, peptide-based, and polyethylene glycol structures, while\nfunctional groups like tosylate and PyTFP are used for efficient [&lt;sup&gt;18&lt;\/sup&gt;F]fluorination. This review\naims to elucidate the main linker and reactions in order to optimize these components\nto improve imaging sensitivity and specificity in detecting prostate cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673333642250102080759","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:33:58Z","timestamp":1737441238000},"page":"6999-7016","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The [18F] F-PSMA Probe: Chemical Perspectives"],"prefix":"10.2174","volume":"32","author":[{"given":"Stephanie Nascimento","family":"Neves-da-Silva","sequence":"first","affiliation":[{"name":"Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, Brazilian Nuclear Energy Commission,\nNuclear Engineering Institute, Rio de Janeiro, 21941906, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Xavier-de-Britto","sequence":"additional","affiliation":[{"name":"Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, Brazilian Nuclear Energy Commission,\nNuclear Engineering Institute, Rio de Janeiro, 21941906, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Magalhaes Rebelo","family":"Alencar","sequence":"additional","affiliation":[{"name":"Laboratory of Biophysics and Nanosystems, Department of Physics, Federal University of Maranh\u00e3o, Campus Bacanga, S\u00e3o Lu\u00eds, Maranh\u00e3o, 65080-805, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Basilio Almeida","family":"Fechine","sequence":"additional","affiliation":[{"name":"Advanced Chemistry Materials Group (GQMat), Analytical Chemistry and Physical Chemistry Department, Federal Unversity of Cear\u00e1, - UFC, Campus do Pici, CP 12100, 60451-970, Fortaleza, CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Santos-Oliveira","sequence":"additional","affiliation":[{"name":"Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, Brazilian Nuclear Energy Commission,\nNuclear Engineering Institute, Rio de Janeiro, 21941906, Brazil"},{"name":"Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, Rio de Janeiro State University, Rio de Janeiro, 23070200, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"884517","DOI":"10.3389\/fchem.2022.884517","volume":"10","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Lin Q.; Shi H.; Cheng D.; Fluorine-18: Radiochemistry and target-specific PET molecular probes design. Front Chem  2022,10,884517","journal-title":"Front Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radphyschem.2016.05.006","volume":"126","author":"Chaves J.C.","year":"2016","unstructured":"Chaves J.C.; Vargas M.J.; S\u00e1nchez R.S.; Measurement of activation products generated in the [18F] FDG production by a 9.6MeV cyclotron. Radiat Phys Chem  2016,126,32-36","journal-title":"Radiat Phys Chem"},{"key":"ref=3","first-page":"55","volume":"2","author":"Alauddin M.M.","year":"2012","unstructured":"Alauddin M.M.; Positron emission tomography (PET) imaging with (18)F-based radiotracers. Am J Nucl Med Mol Imaging  2012,2(1),55-76","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"19265","DOI":"10.1021\/jacs.3c04548","volume":"145","author":"Rivas M.","year":"2023","unstructured":"Rivas M.; Debnath S.; Giri S.; Noffel Y.M.; Sun X.; Gevorgyan V.; One-pot formal carboradiofluorination of alkenes: A toolkit for positron emission tomography imaging probe development. J Am Chem Soc  2023,145(35),19265-19273","journal-title":"J Am Chem Soc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2174\/1568026614666140202205035","volume":"14","author":"Cole E.","year":"2014","unstructured":"Cole E.; Stewart M.; Littich R.; Hoareau R.; Scott P.; Radiosyntheses using fluorine-18: The art and science of late stage fluorination. Curr Top Med Chem  2014,14(7),875-900","journal-title":"Curr Top Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.chempr.2020.11.022","volume":"7","author":"Zhang X.","year":"2021","unstructured":"Zhang X.; Stereospecific and stereoconvergent nucleophilic substitution reactions at tertiary carbon centers. Chem  2021,7(6),1451-1486","journal-title":"Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.37894","volume":"10","author":"Werner R.A.","year":"2020","unstructured":"Werner R.A.; Derlin T.; Lapa C.; Sheikbahaei S.; Higuchi T.; Giesel F.L.; Behr S.; Drzezga A.; Kimura H.; Buck A.K.; Bengel F.M.; Pomper M.G.; Gorin M.A.; Rowe S.P.;  F-Labeled, PSMA-targeted radiotracers: Leveraging the advantages of radiofluorination for prostate cancer molecular imaging. Theranostics  2020,10(1),1-16","journal-title":"Theranostics"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nucmedbio.2021.12.005","volume":"106-107","author":"Piron S.","year":"2022","unstructured":"Piron S.; Verhoeven J.; Vanhove C.; De Vos F.; Recent advancements in F-labeled PSMA targeting PET radiopharmaceuticals. Nucl Med Biol  2022,106-107,29-51","journal-title":"Nucl Med Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/modpathol.2011.112","volume":"24","author":"Samplaski M.K.","year":"2011","unstructured":"Samplaski M.K.; Heston W.; Elson P.; Magi-Galluzzi C.; Hansel D.E.; Folate hydrolase (prostate-specific membrane antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod Pathol  2011,24(11),1521-1529","journal-title":"Mod Pathol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1084\/jem.20171052","volume":"215","author":"Kaittanis C.","year":"2018","unstructured":"Kaittanis C.; Andreou C.; Hieronymus H.; Mao N.; Foss C.A.; Eiber M.; Weirich G.; Panchal P.; Gopalan A.; Zurita J.; Achilefu S.; Chiosis G.; Ponomarev V.; Schwaiger M.; Carver B.S.; Pomper M.G.; Grimm J.; Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J Exp Med  2018,215(1),159-175","journal-title":"J Exp Med"},{"key":"ref=11","first-page":"227","volume":"20","author":"Hawkey N. M.","year":"2022","unstructured":"Hawkey N. M.; Sartor A. O.; Morris M. J.; Armstrong A. J.; Prostate-specific membrane antigen-targeted theranostics: Past, present, and future approaches. Clin Adv Hematol Oncol  2022,20(4),227-238","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1239118","DOI":"10.3389\/fonc.2023.1239118","volume":"13","author":"Szponar P.","year":"2023","unstructured":"Szponar P.; Petrasz P.; Brze\u017aniakiewicz-Janus K.; Drewa T.; Zorga P.; Adamowicz J.; Precision strikes: PSMA- targeted radionuclide therapy in prostate cancer \u2013 A narrative review. Front Oncol  2023,13,1239118","journal-title":"Front Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.euf.2021.06.006","volume":"8","author":"Sheehan B.","year":"2022","unstructured":"Sheehan B.; Guo C.; Neeb A.; Paschalis A.; Sandhu S.; de Bono J.S.; Prostate-specific membrane antigen biology in lethal prostate cancer and its therapeutic implications. Eur Urol Focus  2022,8(5),1157-1168","journal-title":"Eur Urol Focus"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.3390\/cancers15123133","volume":"15","author":"Deshayes E.","year":"2023","unstructured":"Deshayes E.; Fersing C.; Thibault C.; Roumiguie M.; Pourquier P.; Hou\u00e9d\u00e9 N.; Innovation in radionuclide therapy for the treatment of prostate cancers: Radiochemical perspective and recent therapeutic practices. Cancers  2023,15(12),3133","journal-title":"Cancers"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/RLU.0000000000004967","volume":"49","author":"Calderon Tobar M.N.","year":"2024","unstructured":"Calderon Tobar M.N.; \u00d6nner H.; Yavuz C.; 68Ga-PSMA uptake in solar elastosis. Clin Nucl Med  2024,49(1),106-107","journal-title":"Clin Nucl Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.6004\/jnccn.2022.7070","volume":"21","author":"Mehrens D.","year":"2023","unstructured":"Mehrens D.; Kramer K.K.M.; Unterrainer L.M.; Beyer L.; Bartenstein P.; Froelich M.F.; Tollens F.; Ricke J.; R\u00fcbenthaler J.; Schmidt-Hegemann N.S.; Herlemann A.; Unterrainer M.; Kunz W.G.; Cost-effectiveness analysis of 177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer. J Natl Compr Canc Netw  2023,21(1),43-50.e2","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1007\/s00259-023-06165-9","volume":"50","author":"Sathekge M.","year":"2023","unstructured":"Sathekge M.; Bruchertseifer F.; Vorster M.; Lawal I.O.; Mokoala K.; Reed J.; Maseremule L.; Ndlovu H.; Hlongwa K.; Maes A.; Morgenstern A.; Van de Wiele C.; Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): Preliminary clinical findings. Eur J Nucl Med Mol Imaging  2023,50(7),2210-2218","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7844","author":"Rao Z.","year":"2017","unstructured":"Rao Z.; He Z.; He Y.; Guo Z.; Kong D.; Liu J.; MicroRNA-512-3p is upregulated, and promotes proliferation and cell cycle progression, in prostate cancer cells. Mol Med Rep  2017","journal-title":"Mol Med Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/08853282211011766","volume":"36","author":"Wang H.","year":"2021","unstructured":"Wang H.; Ding L.; Xu F.; He L.; Ye L.; Huang L.; Zhang L.; Luo B.; Construction of novel amphiphilic chitosan-polylactide graft copolymer nanodroplets for contrast enhanced ultrasound tumor imaging. J Biomater Appl  2021,36(4),613-625","journal-title":"J Biomater Appl"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/ijms23031158","volume":"23","author":"Debnath S.","year":"2022","unstructured":"Debnath S.; Zhou N.; McLaughlin M.; Rice S.; Pillai A.K.; Hao G.; Sun X.; PSMA-targeting imaging and theranostic agents-current status and future perspective. Int J Mol Sci  2022,23(3),1158","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"692915","DOI":"10.3389\/fcvm.2021.692915","volume":"8","author":"Guo B.","year":"2021","unstructured":"Guo B.; Li Z.; Tu P.; Tang H.; Tu Y.; Molecular imaging and non-molecular imaging of atherosclerotic plaque thrombosis. Front Cardiovasc Med  2021,8,692915","journal-title":"Front Cardiovasc Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/bjr\/tqae092","volume":"97","author":"Naik M.","year":"2024","unstructured":"Naik M.; Khan S.R.; Lewington V.; Challapalli A.; Eccles A.; Barwick T.D.; Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands. Br J Radiol  2024,97(1160),1391-1404","journal-title":"Br J Radiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1373606","DOI":"10.3389\/fonc.2024.1373606","volume":"14","author":"Yan Y.","year":"2024","unstructured":"Yan Y.; Zhuo H.; Li T.; Zhang J.; Tan M.; Chen Y.; Advancements in PSMA ligand radiolabeling for diagnosis and treatment of prostate cancer: A systematic review. Front Oncol  2024,14,1373606","journal-title":"Front Oncol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1021\/acs.molpharmaceut.4c00020","volume":"21","author":"Wang R.","year":"2024","unstructured":"Wang R.; Jin W.; Luo Y.; Hong H.; Zhao R.; Li L.; Yan L.; Qiao J.; Ploessl K.; Zhu L.; Kung H.F.; Novel [ Ga\/  Lu] Ga\/Lu-AZ-093 as PSMA-targeting agent for diagnosis and radiotherapy. Mol Pharm  2024,21(7),3256-3267","journal-title":"Mol Pharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/cancers15020442","volume":"15","author":"Lundmark F.","year":"2023","unstructured":"Lundmark F.; Abouzayed A.; Rinne S.S.; Timofeev V.; Sipkina N.; Naan M.; Kirichenko A.; Vasyutina M.; Ryzhkova D.; Tolmachev V.; Rosenstr\u00f6m U.; Orlova A.; Preclinical characterisation of PSMA\/GRPR-targeting heterodimer [Ga]Ga-BQ7812 for PET diagnostic imaging of prostate cancer: A step towards clinical translation. Cancers  2023,15(2),442","journal-title":"Cancers"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1199432","DOI":"10.3389\/fonc.2023.1199432","volume":"13","author":"Verhoeven M.","year":"2023","unstructured":"Verhoeven M.; Ruigrok E.A.M.; van Leenders G.J.L.H.; van den Brink L.; Balcioglu H.E.; van Weerden W.M.; Dalm S.U.; GRPR versus PSMA: Expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches. Front Oncol  2023,13,1199432","journal-title":"Front Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40658-022-00487-7","volume":"9","author":"Braune A.","year":"2022","unstructured":"Braune A.; Oehme L.; Freudenberg R.; Hofheinz F.; van den Hoff J.; Kotzerke J.; Hober\u00fcck S.; Comparison of image quality and spatial resolution between F, Ga, and Cu phantom measurements using a digital Biograph Vision PET\/CT. EJNMMI Phys  2022,9(1),58","journal-title":"EJNMMI Phys"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/jjco\/hyaa004","volume":"50","author":"Tateishi U.","year":"2020","unstructured":"Tateishi U.; Prostate-specific membrane antigen (PSMA)\u2013ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer. Jpn J Clin Oncol  2020,50(4),349-356","journal-title":"Jpn J Clin Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"113752","DOI":"10.1016\/j.ejmech.2021.113752","volume":"225","author":"Petrov S.A.","year":"2021","unstructured":"Petrov S.A.; Zyk N.Y.; Machulkin A.E.; Beloglazkina E.K.; Majouga A.G.; PSMA-targeted low-molecular double conjugates for diagnostics and therapy. Eur J Med Chem  2021,225,113752","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/pharmaceutics14051098","volume":"14","author":"Lundmark F.","year":"2022","unstructured":"Lundmark F.; Olanders G.; Rinne S.S.; Abouzayed A.; Orlova A.; Rosenstr\u00f6m U.; Design, synthesis, and evaluation of linker-optimised PSMA-targeting radioligands. Pharmaceutics  2022,14(5),1098","journal-title":"Pharmaceutics"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","volume":"59","author":"Bene\u0161ov\u00e1 M.","year":"2016","unstructured":"Bene\u0161ov\u00e1 M.; Bauder-W\u00fcst U.; Sch\u00e4fer M.; Klika K.D.; Mier W.; Haberkorn U.; Kopka K.; Eder M.; Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-targeting and pharmacokinetic properties of DOTA-conjugated PSMA inhibitors. J Med Chem  2016,59(5),1761-1775","journal-title":"J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"220950","DOI":"10.1098\/rsos.220950","volume":"10","author":"Murce E.","year":"2023","unstructured":"Murce E.; de Blois E.; van den Berg S.; de Jong M.; Seimbille Y.; Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK\/MVK cleavable linkers. R Soc Open Sci  2023,10(3),220950","journal-title":"R Soc Open Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/0929867328666210804092200","volume":"29","author":"Uspenskaya A.A.","year":"2022","unstructured":"Uspenskaya A.A.; Nimenko E.A.; Machulkin A.E.; Beloglazkina E.K.; Majouga A.G.; The importance of linkers in the structure of PSMA ligands. Curr Med Chem  2022,29(2),268-298","journal-title":"Curr Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1039\/D2MD00397J","volume":"14","author":"Failla M.","year":"2023","unstructured":"Failla M.; Floresta G.; Abbate V.; Peptide-based positron emission tomography probes: Current strategies for synthesis and radiolabelling. RSC Med Chem  2023,14(4),592-623","journal-title":"RSC Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41181-021-00141-0","volume":"6","author":"Archibald S.J.","year":"2021","unstructured":"Archibald S.J.; Allott L.; The aluminium-[F]fluoride revolution: Simple radiochemistry with a big impact for radiolabelled biomolecules. EJNMMI Radiopharm Chem  2021,6(1),30","journal-title":"EJNMMI Radiopharm Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bc500475e","volume":"26","author":"Jacobson O.","year":"2015","unstructured":"Jacobson O.; Kiesewetter D.O.; Chen X.; Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem  2015,26(1),1-18","journal-title":"Bioconjug Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1021\/jm801055h","volume":"51","author":"Chen Y.","year":"2008","unstructured":"Chen Y.; Foss C.A.; Byun Y.; Nimmagadda S.; Pullambhatla M.; Fox J.J.; Castanares M.; Lupold S.E.; Babich J.W.; Mease R.C.; Pomper M.G.; Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. J Med Chem  2008,51(24),7933-7943","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1107\/S2053229618005430","volume":"74","author":"Davis R.A.","year":"2018","unstructured":"Davis R.A.; Fettinger J.C.; N, N, N -Trimethyl-5-[(2,3,5,6-tetrafluorophenoxy)carbonyl]pyridin-2-aminium trifluoromethanesulfonate a precursor for the synthesis of 2,3,5,6-tetrafluorophenyl 6-[ F]-fluoronicotinate. Acta Crystallogr C Struct Chem  2018,74(5),604-607","journal-title":"Acta Crystallogr C Struct Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jlcr.3959","volume":"65","author":"Iannone M.N.","year":"2022","unstructured":"Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P.; Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach. J Labelled Comp Radiopharm  2022,65(3),48-62","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1021\/acs.bioconjchem.1c00537","volume":"33","author":"Derks Y.H.W.","year":"2022","unstructured":"Derks Y.H.W.; Rijpkema M.; Amatdjais-Groenen H.I.V.; Loeff C.C.; de Roode K.E.; Kip A.; Laverman P.; L\u00fctje S.; Heskamp S.; L\u00f6wik D.W.P.M.; Strain-promoted azide\u2013alkyne cycloaddition-based PSMA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer. Bioconjug Chem  2022,33(1),194-205","journal-title":"Bioconjug Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/mz300585q","volume":"2","author":"Azagarsamy M.A.","year":"2013","unstructured":"Azagarsamy M.A.; Anseth K.S.; Bioorthogonal click chemistry: An indispensable tool to create multifaceted cell culture scaffolds. ACS Macro Lett  2013,2(1),5-9","journal-title":"ACS Macro Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.3390\/molecules24193567","volume":"24","author":"Mushtaq S.","year":"2019","unstructured":"Mushtaq S.; Yun S.J.; Jeon J.; Recent advances in bioorthogonal click chemistry for efficient synthesis of radiotracers and radiopharmaceuticals. Molecules  2019,24(19),3567","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41181-022-00160-5","volume":"7","author":"Richard M.","year":"2022","unstructured":"Richard M.; Hinnen F.; Kuhnast B.; Novel [F]-labeled thiol for the labeling of Dha- or maleimide-containing biomolecules. EJNMMI Radiopharm Chem  2022,7(1),7","journal-title":"EJNMMI Radiopharm Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.1021\/jacs.8b06730","volume":"140","author":"Gendron T.","year":"2018","unstructured":"Gendron T.; Sander K.; Cybulska K.; Benhamou L.; Sin P.K.B.; Khan A.; Wood M.; Porter M.J.; \u00c5rstad E.; Ring-closing synthesis of dibenzothiophene sulfonium salts and their use as leaving groups for aromatic  F-fluorination. J Am Chem Soc  2018,140(35),11125-11132","journal-title":"J Am Chem Soc"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"104304","DOI":"10.1016\/j.bioorg.2020.104304","volume":"104","author":"Kwon H.","year":"2020","unstructured":"Kwon H.; Lim H.; Ha H.; Choi D.; Son S-H.; Nam H.; Minn I.; Byun Y.; Structure-activity relationship studies of prostate-specific membrane antigen (PSMA) inhibitors derived from \u03b1-amino acid with (S)- or (R)-configuration at P1\u2032 region. Bioorg Chem  2020,104,104304","journal-title":"Bioorg Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"11130","DOI":"10.1093\/nar\/gkaa494","volume":"48","author":"Ptacek J.","year":"2020","unstructured":"Ptacek J.; Zhang D.; Qiu L.; Kruspe S.; Motlova L.; Kolenko P.; Novakova Z.; Shubham S.; Havlinova B.; Baranova P.; Chen S.J.; Zou X.; Giangrande P.; Barinka C.; Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer. Nucleic Acids Res  2020,48(19),11130-11145","journal-title":"Nucleic Acids Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1038\/s41467-021-25746-6","volume":"12","author":"Zhang J.","year":"2021","unstructured":"Zhang J.; Rakhimbekova A.; Duan X.; Yin Q.; Foss C.A.; Fan Y.; Xu Y.; Li X.; Cai X.; Kutil Z.; Wang P.; Yang Z.; Zhang N.; Pomper M.G.; Wang Y.; Ba\u0159inka C.; Yang X.; A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat Commun  2021,12(1),5460","journal-title":"Nat Commun"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/molecules27103062","volume":"27","author":"Holik H.A.","year":"2022","unstructured":"Holik H.A.; Ibrahim F.M.; Elaine A.A.; Putra B.D.; Achmad A.; Kartamihardja A.H.S.; The chemical scaffold of theranostic radiopharmaceuticals: Radionuclide, bifunctional chelator, and pharmacokinetics modifying linker. Molecules  2022,27(10),3062","journal-title":"Molecules"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"20230042","DOI":"10.1002\/VIW.20230042","volume":"4","author":"Li M.","year":"2023","unstructured":"Li M.; Wang S.; Kong Q.; Cheng X.; Yan H.; Xing Y.; Lan X.; Jiang D.; Advances in macrocyclic chelators for positron emission tomography imaging. VIEW  2023,4(5),20230042","journal-title":"VIEW"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"20699","DOI":"10.1021\/acs.inorgchem.3c01983","volume":"62","author":"Blei M.K.","year":"2023","unstructured":"Blei M.K.; Waurick L.; Reissig F.; Kopka K.; Stumpf T.; Drobot B.; Kretzschmar J.; Mamat C.; Equilibrium thermodynamics of macropa complexes with selected metal isotopes of radiopharmaceutical interest. Inorg Chem  2023,62(50),20699-20709","journal-title":"Inorg Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1515\/ract-2018-3090","volume":"107","author":"Okoye N.C.","year":"2019","unstructured":"Okoye N.C.; Baumeister J.E.; Najafi Khosroshahi F.; Hennkens H.M.; Jurisson S.S.; Chelators and metal complex stability for radiopharmaceutical applications. Radiochim Acta  2019,107(9-11),1087-1120","journal-title":"Radiochim Acta"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.3390\/ijms232213789","volume":"23","author":"Petrov S.A.","year":"2022","unstructured":"Petrov S.A.; Yusubov M.S.; Beloglazkina E.K.; Nenajdenko V.G.; Synthesis of radioiodinated compounds. Classical approaches and achievements of recent years. Int J Mol Sci  2022,23(22),13789","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1002\/ejoc.201601638","volume":"2017","author":"Cavina L.","year":"2017","unstructured":"Cavina L.; van der Born D.; Klaren P.H.M.; Feiters M.C.; Boerman O.C.; Rutjes F.P.J.T.; Design of radioiodinated pharmaceuticals: Structural features affecting metabolic stability towards in vivo deiodination. Eur J Org Chem  2017,2017(24),3387-3414","journal-title":"Eur J Org Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/acscentsci.3c01050","volume":"9","author":"Bowden G.D.","year":"2023","unstructured":"Bowden G.D.; Scott P.J.H.; Boros E.; Radiochemistry: A hot field with opportunities for cool chemistry. ACS Cent Sci  2023,9(12),2183-2195","journal-title":"ACS Cent Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13139-015-0377-6","volume":"49","author":"Choi J.Y.","year":"2015","unstructured":"Choi J.Y.; Lee B.C.; Click reaction: An applicable radiolabeling method for molecular imaging. Nucl Med Mol Imaging  2015,49(4),258-267","journal-title":"Nucl Med Mol Imaging"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1021\/acs.bioconjchem.4c00084","volume":"35","author":"Luu T.","year":"2024","unstructured":"Luu T.; Gristwood K.; Knight J.C.; J\u00f6rg M.; Click chemistry: Reaction rates and their suitability for biomedical applications. Bioconjug Chem  2024,35(6),715-731","journal-title":"Bioconjug Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1021\/acs.bioconjchem.3c00286","volume":"34","author":"Bauer D.","year":"2023","unstructured":"Bauer D.; Cornejo M.A.; Hoang T.T.; Lewis J.S.; Zeglis B.M.; Click chemistry and radiochemistry: An update. Bioconjug Chem  2023,34(11),1925-1950","journal-title":"Bioconjug Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"Strazielle N.","year":"2013","unstructured":"Strazielle N.; Ghersi-Egea J.F.; Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm  2013,10(5),1473-1491","journal-title":"Mol Pharm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"Nau R.","year":"2010","unstructured":"Nau R.; S\u00f6rgel F.; Eiffert H.; Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev  2010,23(4),858-883","journal-title":"Clin Microbiol Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.2349\/biij.2.4.e59","volume":"2","author":"Sarji S.A.","year":"2006","unstructured":"Sarji S.A.; Physiological uptake in FDG PET simulating disease. Biomed Imaging Interv J  2006,2(4),e59","journal-title":"Biomed Imaging Interv J"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nucmedbio.2016.08.015","volume":"44","author":"Lever S.Z.","year":"2017","unstructured":"Lever S.Z.; Fan K.H.; Lever J.R.; Tactics for preclinical validation of receptor-binding radiotracers. Nucl Med Biol  2017,44,4-30","journal-title":"Nucl Med Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/acsomega.9b02344","volume":"5","author":"Kiani Y.S.","year":"2020","unstructured":"Kiani Y.S.; Jabeen I.; Lipophilic metabolic efficiency (LipMetE) and drug efficiency indices to explore the metabolic properties of the substrates of selected cytochrome P450 Sci World Jisoforms. ACS Omega  2020,5(1),179-188","journal-title":"ACS Omega"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"676719","DOI":"10.1155\/2015\/676719","volume":"2015","author":"Tsopelas C.","year":"2015","unstructured":"Tsopelas C.; Radiotracers used for the scintigraphic detection of infection and inflammation. Sci World J  2015,2015(1),676719","journal-title":"Sci World J"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"16186","DOI":"10.3390\/molecules200916186","volume":"20","author":"Kuchar M.","year":"2015","unstructured":"Kuchar M.; Mamat C.; Methods to increase the metabolic stability of 18F-radiotracers. Molecules  2015,20(9),16186-16220","journal-title":"Molecules"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","volume":"87","author":"Fan J.","year":"2014","unstructured":"Fan J.; de Lannoy I.A.M.; Pharmacokinetics. Biochem Pharmacol  2014,87(1),93-120","journal-title":"Biochem Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.semnuclmed.2021.10.003","volume":"52","author":"Hansen S.B.","year":"2022","unstructured":"Hansen S.B.; Bender D.; Advancement in production of radiotracers. Semin Nucl Med  2022,52(3),266-275","journal-title":"Semin Nucl Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semradonc.2020.07.002","volume":"31","author":"Morris Z.S.","year":"2021","unstructured":"Morris Z.S.; Wang A.Z.; Knox S.J.; The radiobiology of radiopharmaceuticals. Semin Radiat Oncol  2021,31(1),20-27","journal-title":"Semin Radiat Oncol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/B0-12-369397-7\/00527-6","author":"Stringer R.E.","year":"2005","unstructured":"Stringer R.E.; Radiochemical methods | Pharmaceutical Applications. Encyclopedia of Analytical Science  2005,86-93","journal-title":"Encyclopedia of Analytical Science"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"Boellaard R.","year":"2015","unstructured":"Boellaard R.; Delgado-Bolton R.; Oyen W.J.G.; Giammarile F.; Tatsch K.; Eschner W.; Verzijlbergen F.J.; Barrington S.F.; Pike L.C.; Weber W.A.; Stroobants S.; Delbeke D.; Donohoe K.J.; Holbrook S.; Graham M.M.; Testanera G.; Hoekstra O.S.; Zijlstra J.; Visser E.; Hoekstra C.J.; Pruim J.; Willemsen A.; Arends B.; Kotzerke J.; Bockisch A.; Beyer T.; Chiti A.; Krause B.J.; FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0. Eur J Nucl Med Mol Imaging  2015,42(2),328-354","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.apradiso.2008.08.015","volume":"67","author":"Scott P. J.","year":"2009","unstructured":"Scott P. J.; Hockley B. G.; Kung H. F.; Manchanda R.; Zhang W.; Kilbourn M. R.; Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography. Appl Radiat Isot  2009,67(1),88-94","journal-title":"Appl Radiat Isot"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.apradiso.2009.01.005","volume":"67","author":"Jacobson M. S.","year":"2009","unstructured":"Jacobson M. S.; Dankwart H. R.; Mahoney D. W.; Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration. Appl Radiat Isot  2009,67(6),990-995","journal-title":"Appl Radiat Isot"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1017\/S1431927619009103","volume":"25","author":"Jiang N.","year":"2019","unstructured":"Jiang N.; Damage by induced electric field versus radiolysis. Microsc Microanal  2019,25(S2),1674-1675","journal-title":"Microsc Microanal"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"25860","DOI":"10.1021\/acsomega.2c03540","volume":"7","author":"Domnanich K.A.","year":"2022","unstructured":"Domnanich K.A.; Severin G.W.; A model for radiolysis in a flowing-water target during high-intensity proton irradiation. ACS Omega  2022,7(29),25860-25873","journal-title":"ACS Omega"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1021\/ja00883a003","volume":"84","author":"Geissler P.R.","year":"1962","unstructured":"Geissler P.R.; Willard J.E.; Solute-solvent interactions in the radiolysis of alkyl halide-pentane solutions J Am Chem Soc  1962,84(24),4627-4633","journal-title":"J Am Chem Soc"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3571923","volume":"28","author":"Weiss J.","year":"1966","unstructured":"Weiss J.; Collins C.H.; Radiolysis of aromatic compounds: Toluene. Radiat Res  1966,28(1),1-12","journal-title":"Radiat Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"14510","DOI":"10.3390\/ijms241914510","volume":"24","author":"Feldman V.I.","year":"2023","unstructured":"Feldman V.I.; Astrochemically relevant radicals and radical\u2013molecule complexes: A new insight from matrix isolation. Int J Mol Sci  2023,24(19),14510","journal-title":"Int J Mol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2307\/3571657","volume":"22","author":"Wiley R.H.","year":"1964","unstructured":"Wiley R.H.; Patterson R.L.S.; Chesnut G.F.; Gr\u00fcnhut E.; The gamma-irradiation-induced decomposition of amides in carbon tetrachloride. Radiat Res  1964,22(2),253-263","journal-title":"Radiat Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhazmat.2010.01.028","volume":"177","author":"Yu S.","year":"2010","unstructured":"Yu S.; Hu J.; Wang J.; Gamma radiation-induced degradation of p-nitrophenol (PNP) in the presence of hydrogen peroxide (H2O2) in aqueous solution. J Hazard Mater  2010,177(1-3),1061-1067","journal-title":"J Hazard Mater"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1070\/RC2004v073n01ABEH000865","volume":"73","author":"Ershov B.G.","year":"2004","unstructured":"Ershov B.G.; Kinetics, mechanism and intermediates of some radiation-induced reactions in aqueous solutions. Russ Chem Rev  2004,73(1),101-113","journal-title":"Russ Chem Rev"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2307\/3573444","volume":"53","author":"Owen T.C.","year":"1973","unstructured":"Owen T.C.; Ellis D.R.; Radiation-induced mixed-disulfide formation from cystamine and aliphatic disulfides in aqueous solution. Radiat Res  1973,53(1),24-32","journal-title":"Radiat Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2307\/3573994","volume":"59","author":"Raleigh J.A.","year":"1974","unstructured":"Raleigh J.A.; Whitehouse R.; Kremers W.; Effect of oxygen and nitroaromatic cell radiosensitizers on radiation-induced phosphate release from 3\u2032 and 5\u2032-nucleotides: A model for nucleic acids. Radiat Res  1974,59(2),453-465","journal-title":"Radiat Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2307\/3573627","volume":"51","author":"Knight J. A.","year":"1972","unstructured":"Knight J. A.; Radiolysis of aniline. Radiat Res  1972,51(3),590-598","journal-title":"Radiat Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1139\/v77-458","volume":"55","author":"Willis C.","year":"1977","unstructured":"Willis C.; Back R.A.; Morris R.H.; Radiation chemistry of acetylene at high intensity: The initial product distributions. Can J Chem  1977,55(18),3288-3293","journal-title":"Can J Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1039\/C7OB00791D","volume":"15","author":"Tu Y.J.","year":"2017","unstructured":"Tu Y.J.; Njus D.; Schlegel H.B.; A theoretical study of ascorbic acid oxidation and HOO \u02d9\/ O  \u02d9  radical scavenging. Org Biomol Chem  2017,15(20),4417-4431","journal-title":"Org Biomol Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.radphyschem.2015.12.011","volume":"124","author":"Kozm\u00e9r Z.","year":"2016","unstructured":"Kozm\u00e9r Z.; Tak\u00e1cs E.; Wojn\u00e1rovits L.; Alapi T.; Hern\u00e1di K.; Dombi A.; The influence of radical transfer and scavenger materials in various concentrations on the gamma radiolysis of phenol. Radiat Phys Chem  2016,124,52-57","journal-title":"Radiat Phys Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.1039\/c3cp50743b","volume":"15","author":"Haya L.","year":"2013","unstructured":"Haya L.; Osante I.; Mainar A.M.; Cativiela C.; Urieta J.S.; Intramolecular hydrogen-bonding activation in cysteines: A new effective radical scavenger. Phys Chem Chem Phys  2013,15(23),9407-9413","journal-title":"Phys Chem Chem Phys"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1021\/ja9837102","volume":"121","author":"Ciriano M.V.","year":"1999","unstructured":"Ciriano M.V.; Korth H-G.; van Scheppingen W.B.; Mulder P.; Thermal stability of 2,2,6,6-Tetramethyl- piperidine-1-oxyl (TEMPO) and related N -alkoxyamines. J Am Chem Soc  1999,121(27),6375-6381","journal-title":"J Am Chem Soc"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0278-6915(02)00329-0","volume":"41","author":"Sroka Z.","year":"2003","unstructured":"Sroka Z.; Cisowski W.; Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem Toxicol  2003,41(6),753-758","journal-title":"Food Chem Toxicol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/B978-0-444-53748-5.00007-1","author":"Reddy V.P.","year":"2015","unstructured":"Reddy V.P.; Chapter 7-Organofluorine compounds as positron emission tomography tracers. Organofluorine Compounds in Biology and Medicine  2015,201-240","journal-title":"Organofluorine Compounds in Biology and Medicine"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1039\/D3QO00772C","volume":"10","author":"Luu T.G.","year":"2023","unstructured":"Luu T.G.; Kim H.K.; Recent progress on radiofluorination using metals: Strategies for generation of C\u2013 F bonds. Org Chem Front  2023,10(22),5746-5781","journal-title":"Org Chem Front"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"883866","DOI":"10.3389\/fchem.2022.883866","volume":"10","author":"Liu Z.","year":"2022","unstructured":"Liu Z.; Sun Y.; Liu T.; Recent advances in synthetic methodologies to form C-F bonds. Front Chemical  2022,10,883866","journal-title":"Front Chemical"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/catal13030479","volume":"13","author":"Oh Y.H.","year":"2023","unstructured":"Oh Y.H.; Jeong J.G.; Kim D.W.; Lee S.; Nucleophilic reactions using alkali metal fluorides activated by crown ethers and derivatives. Catalysts  2023,13(3),479-479","journal-title":"Catalysts"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.3390\/molecules26102947","volume":"26","author":"Oh Y.H.","year":"2021","unstructured":"Oh Y.H.; Yun W.; Kim C.H.; Jang S.W.; Lee S.S.; Lee S.; Kim D.W.; Inter- and intra-molecular organocatalysis of S2 fluorination by crown ether: Kinetics and quantum chemical analysis. Molecules  2021,26(10),2947","journal-title":"Molecules"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ph14090833","volume":"14","author":"Shinde S.S.","year":"2021","unstructured":"Shinde S.S.; Bolik K.V.; Maschauer S.; Prante O.; F-fluorination using tri-tert-butanol ammonium iodide as phase-transfer catalyst: An alternative minimalist approach. Pharmaceuticals  2021,14(9),833","journal-title":"Pharmaceuticals"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61845-y","volume":"10","author":"Inkster J. a. H.","year":"2020","unstructured":"Inkster J. a. H.; Akurathi V.; Sromek A. W.; Chen Y.; Neumeyer J. L.; Packard A. B.; A non-anhydrous, minimally basic protocol for the simplification of nucleophilic 18 F-fluorination chemistry. Scientific Reports  2020,10(1),1-9","journal-title":"Scientific Reports"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"687678","DOI":"10.3389\/fchem.2021.687678","volume":"9","author":"Scroggie K.R.","year":"2021","unstructured":"Scroggie K.R.; Perkins M.V.; Chalker J.M.; Reaction of [F] fluoride at heteroatoms and metals for imaging of peptides and proteins by positron emission tomography. Front Chem  2021,9,687678","journal-title":"Front Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/molecules24162866","volume":"24","author":"Fersing C.","year":"2019","unstructured":"Fersing C.; Bouhlel A.; Cantelli C.; Garrigue P.; Lisowski V.; Guillet B.; A comprehensive review of non-covalent radiofluorination approaches using aluminum [F]fluoride: Will [F]AlF replace Ga for metal chelate labeling? Molecules  2019,24(16),2866","journal-title":"Molecules"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/app12010321","volume":"12","author":"Krasikova R.N.","year":"2021","unstructured":"Krasikova R.N.; Orlovskaya V.V.; Phase transfer catalysts and role of reaction environment in nucleophilc radiofluorinations in automated synthesizers. Appl Sci  2021,12(1),321-321","journal-title":"Appl Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e202300248","DOI":"10.1002\/chem.202300248","volume":"29","author":"Zhang K.","year":"2023","unstructured":"Zhang K.; Feng W.; Mou Z.; Chen J.; Tang X.; Li Z.; F-labeling chemistry in aqueous media. Chemistry  2023,29(37),e202300248","journal-title":"Chemistry"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"111979","DOI":"10.1016\/j.ejmech.2019.111979","volume":"187","author":"Goud N.S.","year":"2020","unstructured":"Goud N.S.; Joshi R.K.; Bharath R.D.; Kumar P.; Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis. Eur J Med Chem  2020,187,111979","journal-title":"Eur J Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13550-020-00692-4","volume":"10","author":"Ghosh K.K.","year":"2020","unstructured":"Ghosh K.K.; Padmanabhan P.; Yang C.T.; Mishra S.; Halldin C.; Guly\u00e1s B.; Dealing with PET radiometabolites. EJNMMI Res  2020,10(1),109","journal-title":"EJNMMI Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/jms.925","volume":"40","author":"Lengqvist J.","year":"2005","unstructured":"Lengqvist J.; Mata de Urquiza A.; Perlmann T.; Sj\u00f6vall J.; Griffiths W.J.; Specificity of receptor\u2013ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: Bile acids form stable adducts to the RXR\u03b1. J Mass Spectrom  2005,40(11),1448-1461","journal-title":"J Mass Spectrom"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673333642250102080759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238590\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673333642250102080759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:15:33Z","timestamp":1759119333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238590\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":102,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673333642250102080759","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}